Suppr超能文献

原发性甲状旁腺功能亢进症患者的血浆1,25-二羟维生素D水平取决于性别、体重指数、血浆磷酸盐和肾功能。

Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.

作者信息

Moosgaard B, Vestergaard P, Heickendorff L, Mosekilde L

机构信息

Department of Endocrinology and Metabolism C, Aarhus University Hospital, Aarhus C, Denmark.

出版信息

Clin Endocrinol (Oxf). 2007 Jan;66(1):35-42. doi: 10.1111/j.1365-2265.2006.02680.x.

Abstract

BACKGROUND

Primary hyperparathyroidism (PHPT) is characterized by elevated plasma levels of PTH and calcium with reduced plasma phosphate. Physiologically, renal 1alpha,25-dihydroxyvitamin D [1,25(OH)(2)D] production is stimulated by PTH and phosphate deprivation, and inhibited by 1,25(OH)(2)D itself and calcium.

AIM

To investigate relations between circulating levels of 1,25(OH)(2)D, 25-dihydroxyvitamin D (25OHD), PTH, calcium, phosphate, renal function and skeletal complications in patients with PHPT.

DESIGN

Cross-sectional study.

MATERIAL

Two hundred and fifty-two consecutive hypercalcaemic Caucasian patients aged 24-91 (median 65.9) years (85.3% females) with PHPT.

RESULTS

In patients with PHPT, plasma 1,25(OH)(2)D was increased by 27%[107 (9-250) pmol/l, median (range)] compared to controls [84 (18-172) pmol/l, P < 0.001]. In univariate models, plasma 1,25(OH)(2)D depended inversely on age (r = -0.23, P < 0.001) and plasma phosphate (r = -0.23, P < 0.001) and positively on plasma calcium (r = 0.14, P < 0.05), plasma 25OHD (r = 0,15, P < 0.05) and creatinine clearance rate (r = 0.32, P < 0.001). In the final multiple regression model, plasma 1,25(OH)(2)D depended positively on renal function (r(p) = 0.43, P < 0.001) and female sex (r(p) = 0.15, P < 0.05) but inversely on body mass index (BMI; r(p) = -0.23, P < 0.005) and plasma phosphate (r(p) = -0.18, P < 0.05). Plasma 1,25(OH)(2)D correlated positively with renal calcium excretion and inversely with lumbar spine bone mineral density (BMD) but was not associated with risk of fractures or renal stones.

CONCLUSION

Patients with PHPT have elevated plasma 1,25(OH)(2)D levels but, to a large extent, individual values overlap controls. The increase in plasma 1,25(OH)(2)D depends on renal function, hypophosphataemia and the female sex and is attenuated by high BMI. High plasma 1,25(OH)(2)D is associated with higher plasma calcium levels.

摘要

背景

原发性甲状旁腺功能亢进症(PHPT)的特征是血浆甲状旁腺激素(PTH)水平升高、血钙升高以及血磷降低。生理情况下,PTH和低磷可刺激肾脏生成1α,25-二羟维生素D [1,25(OH)₂D],而1,25(OH)₂D本身和血钙则会抑制其生成。

目的

研究PHPT患者循环中1,25(OH)₂D、25-羟维生素D(25OHD)、PTH、钙、磷、肾功能及骨骼并发症之间的关系。

设计

横断面研究。

材料

252例连续入选的高钙血症白种人PHPT患者,年龄24 - 91岁(中位数65.9岁),女性占85.3%。

结果

与对照组相比,PHPT患者血浆1,25(OH)₂D升高了27%[107(9 - 250)pmol/l,中位数(范围)],对照组为[84(18 - 172)pmol/l,P < 0.001]。在单变量模型中,血浆1,25(OH)₂D与年龄呈负相关(r = -0.23,P < 0.001)、与血磷呈负相关(r = -0.23,P < 0.001),与血钙呈正相关(r = 0.14,P < 0.05)、与血浆25OHD呈正相关(r = 0.15,P < 0.05)以及与肌酐清除率呈正相关(r = 0.32,P < 0.001)。在最终的多元回归模型中,血浆1,25(OH)₂D与肾功能呈正相关(r(p) = 0.43,P < 0.001)、与女性性别呈正相关(r(p) = 0.15,P < 0.05),但与体重指数(BMI;r(p) = -0.23,P < 0.005)和血磷呈负相关(r(p) = -0.18,P < 0.05)。血浆1,25(OH)₂D与肾钙排泄呈正相关,与腰椎骨密度(BMD)呈负相关,但与骨折或肾结石风险无关。

结论

PHPT患者血浆1,25(OH)₂D水平升高,但在很大程度上个体值与对照组重叠。血浆1,25(OH)₂D的升高取决于肾功能、低磷血症和女性性别,并因高BMI而减弱。高血浆1,25(OH)₂D与较高的血浆钙水平相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验